Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy

Table 1 Baseline and clinical characteristics, n (%)

Initial variables	Results, n = 10
Gender (female)	3 (30)
Age (yr)	29.00 ± 15.87
Weight (kg)	54.23 ± 27.17
Height (m)	1.62 ± 0.08
Body mass index (kg/m2)	20.11 ± 7.90
Diagnosis-biopsy time (months)	60 (39-60)
Hypertension	5 (50)
Use loop of Henle diuretics	3 (30)
Spironolactone use	2 (20)
Use of ACE inhibitors	5 (50)
Antiplatelet use	2 (20)
Warfarin use	1 (10)
Surgery prior to kidney biopsy	5 (50)
Serum creatinine (mg/dL)	1.73 ± 2.10
Blood urea nitrogen (mg/dL)	30.57 ± 29.32
Proteinuria (mg/24 h)	4843 (4079-6490)
Hemoglobin (g/L)	15.33 ± 4.45
Hematocrit (%)	48.07 ± 17.32
Platelets × 109/L	288.00 ± 82.00
Hematuria	0 (0)

ACE: Angiotensin-converting enzyme; BUN: Blood urea nitrogen.